Health Care/Hospital

Landmark Study of Avastin in Lung Cancer Published Today in New England Journal of Medicine

- Avastin is First Medicine to Extend Survival Beyond One Year in Patients with Previously Untreated Non-Small Cell Lung Cancer BASEL, Switzerland, Dec. 14 /Xinhua-PRNewswire/ -- Avastin is the first medicine proven to help previously untreated patients suffering from the most common ...

2006-12-14 09:38 841

New VaccineS Against Cervical Cancer Major Opportunity for Developing World

LONDON and GENEVA, Dec. 13 /Xinhua-PRNewswire/ -- The introduction of new vaccines against Human Papillomavirus (HPV), the virus that causes cervical cancer, could have a major impact on the health of women in the developing world. More than 250 000 women died from cervical cancer in 2005...

2006-12-13 17:08 934

China Sky One Medical Purchases Competitor Heilongjiang Tianlong Pharmaceutical Company

LOS ANGELES, Calif., Dec. 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), one of the leading producers and distributors for external-Chinese medicines in China, has announced that a strategic agreement was reached between Liu Yan-qing, pres...

2006-12-13 21:30 1079

New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke

- The PREVAIL Study Showed That in Acute Ischemic Stroke Patients Treated With Clexane(R) / Lovenox(R), the Risk of Having a VTE was Lowered by a Significant 43% With no Significant Increase in Clinically Important Bleedings When Compared to UFH ORLANDO,...

2006-12-13 09:47 1092

Xeloda Meets Primary Endpoint in Multinational Phase III Advanced Colorectal Cancer Study

- Roche to Approach World-Wide Regulatory Authorities for a New File Submission BASEL, Switzerland, Dec. 11 /Xinhua-PRNewswire/ -- Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its pri...

2006-12-11 14:30 879

Data Presented to FDA Panel Show TAXUS(TM) Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures

PARIS, Dec. 11 /Xinhua-PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) yesterday presented data on its long-term randomized clinical trials to a special U.S. Food and Drug Administration (FDA) panel, showing that the TAXUS(TM) paclitaxel-eluting coronary stent is as safe as bare-m...

2006-12-11 09:38 831

The International Myeloma Foundation: Multiple Studies at Global Cancer Conference Show New Therapies Changing the Outlook for Patients With Blood Cancers

- Studies Presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) ORLANDO, Fla., and NORTH HOLLYWOOD, Calif., Dec. 8 /Xinhua-PRNewswire/ -- The International Myeloma Foundation (IMF) -- conducting research and providing education, advocacy and support for mye...

2006-12-08 22:00 1083

A New Gold Standard in Early Breast Cancer as Arimidex(TM) (Anastrozole) Overtakes Tamoxifen

-- More Patients Set to Benefit as Weight of Evidence for 'Arimidex' Prompts Wave of Change MACCLESFIELD, England, Dec. 7 /Xinhua-PRNewswire/ -- Today, for the first time in over 20 years, a new gold standard treatment has emerged for postmenopausal women with early breast cancer. I...

2006-12-07 19:33 1046

WuXi PharmaTech Announces Expanded Agreement with Merck & Co., Inc.

SHANGHAI, China, Dec. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech Co. Ltd., China’s leading pharmaceutical R&D service company, announced today that Merck & Co., Inc., of Whitehouse Station, NJ, USA, has agreed to extend and expand an agreement through which WuXi provides a variety of chemist...

2006-12-07 21:00 1320

SAMHSA and Ad Council Unveil National Mental Health Anti-Stigma Campaign - Video Available

Only One in Four Americans Believes People are Sympathetic Towards Those With Mental Illnesses WASHINGTON, Dec. 4 /PRNewswire/ -- The Substance Abuse and Mental Health Services Administration (SAMHSA), in partnership with the Ad Council, today launched a national awareness public service ...

2006-12-05 13:48 1241

Global Strategy Aims For Effective Malaria Vaccine By 2025

BANGKOK, Thailand, Dec. 5 /Xinhua-PRNewswire/ -- A report by the world’s leading international health organizations today calls for joint action to accelerate the development and licensing of a highly effective malaria vaccine. The Malaria Vaccine Technology Roadmap, a new global s...

2006-12-05 11:54 867

China Medicine Reports Third Quarter Results

GUANGZHOU, China, Dec. 4 /PRNewswire-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME), a leading distributor of medical products, traditional pharmaceutical and Chinese medicines, herbs and dietary supplements today is reporting third quarter financial results for the pe...

2006-12-04 22:00 779

The Research and Development Center of Harbin First Bio-Engineering Co., Ltd., a Wholly Owned Subsidiary of China Sky One Medical, Inc. (OTC Bulletin Board: CSKI) is Named as key Provincial Laboratory by Heilongjiang Provincial Science and Technology Department

LOS ANGELES, Dec. 4 /Xinhua-PRNewswire/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI) has been notified that at an accreditation meeting on November 21, the research and development center of Harbin First Bio- engineering Co., Ltd., a wholly owned subsidiary of China Sky One, wa...

2006-12-04 21:30 1454

Cathay Industrial Biotech Completes US$52 Million Series B Financing

SHANGHAI, China, Dec. 4 /Xinhua-PRNewswire/ -- Cathay Industrial Biotech Ltd. (CIB) today announced the closing of its US$52 million Series B financing. Together with the US$26 million Series A financing in May 2006, CIB has raised a total of US$78 million in 2006. Series B Invest...

2006-12-04 21:00 1115

Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs

-- New Results From the Only Large European Study Combining Blood Pressure-Lowering With Cholesterol Reduction in Patients With Moderate Cardiac Risk Prevents Half of Heart Attacks LONDON, Dec. 4 /Xinhua-PRNewswire/ -- The risk of heart attack can be reduced by more t...

2006-12-04 16:01 1063

WORLD AIDS DAY MESSAGE

GENEVA, Dec. 1 /Xinhua-PRNewswire/ -- The HIV/AIDS epidemic continues to grow. Some 40 million people, their families, and their communities, are now living with HIV. Effectively tackling this epidemic remains one of the world’s most pressing public health challenges. (Logo: http...

2006-12-01 17:24 910

UNDP recognizes community-based AIDS response in China

AIDS Care China honoured by the inaugural UN Red Ribbon Award BEIJING, China, Dec. 1 /Xinhua-PRNewswire/ -- Against the backdrop of World AIDS Day, the United Nations in China presented today AIDS Care China with the inaugural Red Ribbon Award for the organization’s community-based a...

2006-12-01 10:31 1665

Winner Medical Group Inc. Successfully Completes Second Phase of ERP Project

- SAP ERP System Will Facilitate Compliance with Sarbanes-Oxley as Well as Help to Better Manage Future Growth - SHENZHEN, China, Nov. 28 /Xinhua-PRNewswire/ -- Winner Medical Group Inc., "Winner Medical" (OTC Bulletin Board: WMDG), has successfully completed the second phase of its Ent...

2006-11-28 21:30 1050

Study Shows Pregabalin Effective in Difficult-to-Treat Nerve Pain

Results Offer Hope to Patients with Excruciating Chronic Pain SYDNEY, Australia, Nov. 28 /Xinhua-PRNewswire/ -- Findings from a new study published today in the journal Neurology demonstrate that the oral medication pregabalin is significantly effective in relieving central neuropathi...

2006-11-28 17:00 806

WuXi PharmaTech Ranks 27th on Deloitte Tech’s Fast 50 China

SHANGHAI, China, Nov. 27 /Xinhua-PRNewswire/ -- Shanghai, China - WuXi PharmaTech, China’s leading drug R&D service company, announced today it has been chosen in the “Deloitte Technology Fast 50 China 2006”, a ranking of the 50 fastest growing technology companies in China, for the second...

2006-11-27 21:00 1086